• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

氨基酸示踪剂 PET MRI 在胶质瘤管理中的应用:神经放射科医生需要了解的内容。

Amino Acid Tracer PET MRI in Glioma Management: What a Neuroradiologist Needs to Know.

机构信息

From the University of Rochester Medical Center (N.S., S.E., J.A., S.P., S.M.), Rochester, New York

Sanjay Gandhi Postgraduate Institute of Medical Sciences (M.O.), Lucknow, Uttar Pradesh, India.

出版信息

AJNR Am J Neuroradiol. 2023 Mar;44(3):236-246. doi: 10.3174/ajnr.A7762. Epub 2023 Jan 19.

DOI:10.3174/ajnr.A7762
PMID:36657945
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10187808/
Abstract

PET with amino acid tracers provides additional insight beyond MR imaging into the biology of gliomas that can be used for initial diagnosis, delineation of tumor margins, planning of surgical and radiation therapy, assessment of residual tumor, and evaluation of posttreatment response. Hybrid PET MR imaging allows the simultaneous acquisition of various PET and MR imaging parameters in a single investigation with reduced scanning time and improved anatomic localization. This review aimed to provide neuroradiologists with a concise overview of the various amino acid tracers and a practical understanding of the clinical applications of amino acid PET MR imaging in glioma management. Future perspectives in newer advances, novel radiotracers, radiomics, and cost-effectiveness are also outlined.

摘要

正电子发射断层扫描(PET)与氨基酸示踪剂为胶质瘤的生物学特性提供了比磁共振成像(MR)更深入的了解,可以用于初始诊断、肿瘤边界的划定、手术和放疗计划、残留肿瘤的评估以及治疗后反应的评估。PET-MR 成像允许在单次检查中同时采集各种 PET 和 MR 成像参数,从而减少扫描时间并提高解剖定位的准确性。本综述旨在为神经放射科医生提供各种氨基酸示踪剂的简明概述,并对氨基酸 PET-MR 成像在胶质瘤管理中的临床应用有实际的了解。本文还概述了新进展、新型放射性示踪剂、影像组学和成本效益方面的未来展望。

相似文献

1
Amino Acid Tracer PET MRI in Glioma Management: What a Neuroradiologist Needs to Know.氨基酸示踪剂 PET MRI 在胶质瘤管理中的应用:神经放射科医生需要了解的内容。
AJNR Am J Neuroradiol. 2023 Mar;44(3):236-246. doi: 10.3174/ajnr.A7762. Epub 2023 Jan 19.
2
[Use of amino acid PET in the Diagnostic and Treatment Management of cerebral gliomas].[氨基酸正电子发射断层扫描在脑胶质瘤诊断及治疗管理中的应用]
Fortschr Neurol Psychiatr. 2012 Jan;80(1):17-23. doi: 10.1055/s-0031-1281851. Epub 2011 Dec 12.
3
Multimodal imaging utilising integrated MR-PET for human brain tumour assessment.多模态成像利用集成的 MR-PET 进行人脑肿瘤评估。
Eur Radiol. 2012 Dec;22(12):2568-80. doi: 10.1007/s00330-012-2543-x. Epub 2012 Jul 11.
4
Role of Molecular Imaging with PET/MR Imaging in the Diagnosis and Management of Brain Tumors.正电子发射断层磁共振成像在脑肿瘤诊断与治疗中的作用
PET Clin. 2022 Jul;17(3):431-451. doi: 10.1016/j.cpet.2022.03.002. Epub 2022 May 31.
5
Evaluation of trans-1-amino-3-18F-fluorocyclobutanecarboxylic acid accumulation in low-grade glioma in chemically induced rat models: PET and autoradiography compared with morphological images and histopathological findings.在化学诱导大鼠模型中评估反式-1-氨基-3-¹⁸F-氟环丁烷羧酸在低级别胶质瘤中的蓄积:正电子发射断层扫描(PET)和放射自显影与形态学图像及组织病理学结果的比较
Nucl Med Biol. 2015 Aug;42(8):664-72. doi: 10.1016/j.nucmedbio.2015.04.008. Epub 2015 May 7.
6
Comparison of 18F-FET PET and perfusion-weighted MR imaging: a PET/MR imaging hybrid study in patients with brain tumors.18F-FET PET 与灌注加权磁共振成像的比较:脑肿瘤患者的 PET/MR 成像杂交研究。
J Nucl Med. 2014 Apr;55(4):540-5. doi: 10.2967/jnumed.113.129007. Epub 2014 Feb 27.
7
Brain Tumors: An Update on Clinical PET Research in Gliomas.脑肿瘤:胶质瘤临床正电子发射断层显像(PET)研究的最新进展
Semin Nucl Med. 2017 Jan;47(1):5-17. doi: 10.1053/j.semnuclmed.2016.09.004. Epub 2016 Sep 27.
8
L-(methyl-11C) methionine positron emission tomography for target delineation in resected high-grade gliomas before radiotherapy.L-(甲基-11C)蛋氨酸正电子发射断层扫描在放疗前对切除的高级别胶质瘤进行靶区勾画。
Int J Radiat Oncol Biol Phys. 2005 Sep 1;63(1):64-74. doi: 10.1016/j.ijrobp.2005.01.045.
9
11C-CHO PET in optimization of target volume delineation and treatment regimens in postoperative radiotherapy for brain gliomas.11C-CHO PET 在脑胶质瘤术后放疗靶区勾画和治疗方案优化中的应用。
Nucl Med Biol. 2012 Apr;39(3):437-42. doi: 10.1016/j.nucmedbio.2011.10.003. Epub 2011 Dec 14.
10
Comparison of F-GE-180 and dynamic F-FET PET in high grade glioma: a double-tracer pilot study.F-GE-180 与动态 F-FET PET 对比在高级别胶质瘤中的应用:一项双示踪剂初步研究。
Eur J Nucl Med Mol Imaging. 2019 Mar;46(3):580-590. doi: 10.1007/s00259-018-4166-1. Epub 2018 Sep 22.

引用本文的文献

1
Amino Acid Transporters in Glioblastoma: Implications for Diagnosis, Disease Monitoring, Therapeutic Targeting, and Drug Delivery.胶质母细胞瘤中的氨基酸转运体:对诊断、疾病监测、治疗靶点及药物递送的意义
Mol Diagn Ther. 2025 Aug 22. doi: 10.1007/s40291-025-00810-9.
2
Radio-chemotherapy and metformin selectively modulate the heterogeneous landscape of glioma with ribosome biogenesis, long non coding RNA and immune-escape markers as major player.放射化疗和二甲双胍通过以核糖体生物合成、长链非编码RNA和免疫逃逸标志物为主要因素,选择性地调节胶质瘤的异质性格局。
Int J Biol Sci. 2025 May 27;21(8):3527-3554. doi: 10.7150/ijbs.103194. eCollection 2025.
3
Energy metabolism in health and diseases.健康与疾病中的能量代谢。
Signal Transduct Target Ther. 2025 Feb 18;10(1):69. doi: 10.1038/s41392-025-02141-x.
4
Pre-operative dual-time-point [F]FET PET differentiates CDKN2A/B loss and PIK3CA mutation status in adult-type diffuse glioma: a single-center prospective study.术前双时间点[F]FET PET鉴别成人型弥漫性胶质瘤中CDKN2A/B缺失和PIK3CA突变状态:一项单中心前瞻性研究
Eur J Nucl Med Mol Imaging. 2025 Jan;52(2):669-682. doi: 10.1007/s00259-024-06935-z. Epub 2024 Oct 4.
5
The significant role of amino acid metabolic reprogramming in cancer.氨基酸代谢重编程在癌症中的重要作用。
Cell Commun Signal. 2024 Jul 29;22(1):380. doi: 10.1186/s12964-024-01760-1.
6
Synthesis and Biological Evaluation of Fluorine-18 and Deuterium Labeled l-Fluoroalanines as Positron Emission Tomography Imaging Agents for Cancer Detection.氟-18 和氘标记 l-氟丙氨酸的合成及生物评价作为癌症检测的正电子发射断层成像剂。
J Med Chem. 2024 Jun 27;67(12):10293-10305. doi: 10.1021/acs.jmedchem.4c00774. Epub 2024 Jun 5.
7
Glioblastoma Therapy: Past, Present and Future.胶质母细胞瘤治疗:过去、现在和未来。
Int J Mol Sci. 2024 Feb 21;25(5):2529. doi: 10.3390/ijms25052529.
8
Advances in Neuro-Oncological Imaging: An Update on Diagnostic Approach to Brain Tumors.神经肿瘤影像学进展:脑肿瘤诊断方法的最新情况
Cancers (Basel). 2024 Jan 30;16(3):576. doi: 10.3390/cancers16030576.
9
Adding Value to Liquid Biopsy for Brain Tumors: The Role of Imaging.为脑肿瘤液体活检增添价值:影像学的作用。
Cancers (Basel). 2023 Oct 29;15(21):5198. doi: 10.3390/cancers15215198.
10
Advances in the Radiological Evaluation of and Theranostics for Glioblastoma.胶质母细胞瘤的放射学评估与诊疗一体化的进展
Cancers (Basel). 2023 Aug 18;15(16):4162. doi: 10.3390/cancers15164162.

本文引用的文献

1
The 2021 World Health Organization Classification of Tumors of the Central Nervous System: What Neuroradiologists Need to Know.《2021 年世界卫生组织中枢神经系统肿瘤分类:神经放射学家需要了解的内容》。
AJNR Am J Neuroradiol. 2022 Jul;43(7):928-937. doi: 10.3174/ajnr.A7462. Epub 2022 Jun 16.
2
Integrin-αvβ3 as a Therapeutic Target in Glioblastoma: Back to the Future?整合素αvβ3作为胶质母细胞瘤的治疗靶点:回归未来?
Pharmaceutics. 2022 May 13;14(5):1053. doi: 10.3390/pharmaceutics14051053.
3
[F]-fluoromisonidazole (FMISO) PET/MRI hypoxic fraction distinguishes neuroinflammatory pseudoprogression from recurrent glioblastoma in patients treated with pembrolizumab.[F]-氟米索硝唑(FMISO)正电子发射断层扫描/磁共振成像(PET/MRI)的缺氧分数可区分接受派姆单抗治疗的患者中神经炎性假性进展与复发性胶质母细胞瘤。
Neurooncol Pract. 2022 Mar 9;9(3):246-250. doi: 10.1093/nop/npac021. eCollection 2022 May.
4
A systematic review of amino acid PET in assessing treatment response to temozolomide in glioma.一项关于氨基酸正电子发射断层扫描(PET)评估胶质瘤对替莫唑胺治疗反应的系统评价。
Neurooncol Adv. 2022 Feb 13;4(1):vdac008. doi: 10.1093/noajnl/vdac008. eCollection 2022 Jan-Dec.
5
What Does PET Imaging Bring to Neuro-Oncology in 2022? A Review.2022年PET成像给神经肿瘤学带来了什么?综述。
Cancers (Basel). 2022 Feb 10;14(4):879. doi: 10.3390/cancers14040879.
6
Feasibility on the Use of Radiomics Features of 11[C]-MET PET/CT in Central Nervous System Tumours: Preliminary Results on Potential Grading Discrimination Using a Machine Learning Model.基于 11[C]-MET PET/CT 影像组学特征在中枢神经系统肿瘤中的可行性研究:利用机器学习模型进行潜在分级诊断的初步结果。
Curr Oncol. 2021 Dec 12;28(6):5318-5331. doi: 10.3390/curroncol28060444.
7
Glioma Imaging by O-(2-18F-Fluoroethyl)-L-Tyrosine PET and Diffusion-Weighted MRI and Correlation With Molecular Phenotypes, Validated by PET/MR-Guided Biopsies.通过O-(2-18F-氟乙基)-L-酪氨酸正电子发射断层扫描(PET)和扩散加权磁共振成像(MRI)对胶质瘤进行成像,并与分子表型进行相关性分析,经PET/MR引导活检验证
Front Oncol. 2021 Nov 29;11:743655. doi: 10.3389/fonc.2021.743655. eCollection 2021.
8
Trends in Intracranial Glioma Incidence and Mortality in the United States, 1975-2018.1975 - 2018年美国颅内胶质瘤的发病率和死亡率趋势
Front Oncol. 2021 Nov 1;11:748061. doi: 10.3389/fonc.2021.748061. eCollection 2021.
9
PET/MR in recurrent glioblastoma patients treated with regorafenib: [F]FET and DWI-ADC for response assessment and survival prediction.替莫唑胺联合放疗同步与序贯卡培他滨治疗新诊断胶质母细胞瘤的多中心随机对照 III 期临床研究
Br J Radiol. 2022 Jan 1;95(1129):20211018. doi: 10.1259/bjr.20211018. Epub 2021 Nov 23.
10
Glutamine Imaging: A New Avenue for Glioma Management.谷氨酰胺成像:胶质瘤管理的新途径。
AJNR Am J Neuroradiol. 2022 Jan;43(1):11-18. doi: 10.3174/ajnr.A7333. Epub 2021 Nov 4.